Trial
NCT02947022
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of North Carolina, Chapel Hill
Collaborators
Hameln Pharma GmbH
Condition
Headache
Intervention
Calcium DTPA
Why stopped
PI left institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-06